Screening for High Lipoprotein(a).
作者信息
Thanassoulis George
机构信息
Preventive and Genomic Cardiology, McGill University Health Center and Research Institute, Montreal, Quebec, Canada.
出版信息
Circulation. 2019 Mar 19;139(12):1493-1496. doi: 10.1161/CIRCULATIONAHA.119.038989.
Abstract
摘要
相似文献
1
Screening for High Lipoprotein(a).
Circulation. 2019 Mar 19;139(12):1493-1496. doi: 10.1161/CIRCULATIONAHA.119.038989.
2
From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients.
Eur J Prev Cardiol. 2018 Nov;25(17):1843-1851. doi: 10.1177/2047487318792626. Epub 2018 Jul 30.
3
Update on proprotein convertase subtilisin/kexin type 9 inhibitors, lipoprotein(a) and cardiovascular risk.
Curr Opin Lipidol. 2021 Oct 1;32(5):324-327. doi: 10.1097/MOL.0000000000000771.
4
Circulating Complex of Lipoprotein(a) and Proprotein Convertase Subtilisin/Kexin Type 9 in the Serum Measured by ELISA.
Bull Exp Biol Med. 2020 Sep;169(5):639-643. doi: 10.1007/s10517-020-04944-0. Epub 2020 Sep 26.
5
Lipoprotein(a) Removal Still a Mystery.
J Am Heart Assoc. 2019 Feb 19;8(4):e011903. doi: 10.1161/JAHA.118.011903.
6
Effect of proprotein convertase subtilisin/kexin type 9 inhibitors on lipoprotein(a) still to be unravelled.
Eur J Prev Cardiol. 2019 May;26(7):782. doi: 10.1177/2047487319825918. Epub 2019 Jan 28.
7
Therapeutic lowering of lipoprotein(a): How much is enough?
Atherosclerosis. 2019 Sep;288:163-165. doi: 10.1016/j.atherosclerosis.2019.07.003. Epub 2019 Jul 5.
8
Lp(a)'s Odyssey: Should We Measure Lp(a) Post-ACS and What Should We Do With the Results?
J Am Coll Cardiol. 2020 Jan 21;75(2):145-147. doi: 10.1016/j.jacc.2019.11.016.
9
Lipoprotein(a) lowering and cardiovascular risk reduction by PCSK9 inhibitors.
Atherosclerosis. 2022 Nov;361:30-31. doi: 10.1016/j.atherosclerosis.2022.10.010. Epub 2022 Oct 21.
10
PCSK9 and Lipoprotein(a): The Plot Thickens.
Circ Res. 2016 Jun 24;119(1):3-6. doi: 10.1161/CIRCRESAHA.116.309011.
引用本文的文献
1
Living with Elevated Lipoprotein(a) Levels: The Experiences of Patients and Caregivers.
Patient Prefer Adherence. 2025 Feb 21;19:395-405. doi: 10.2147/PPA.S478623. eCollection 2025.
2
Can Lp(a) become the next A1C? A case for digital health management tools to overcome inertia to Lipoprotein (a) testing.
Front Cardiovasc Med. 2025 Feb 10;12:1545787. doi: 10.3389/fcvm.2025.1545787. eCollection 2025.
3
High lipoprotein(a): Actionable strategies for risk assessment and mitigation.
Am J Prev Cardiol. 2024 Apr 3;18:100651. doi: 10.1016/j.ajpc.2024.100651. eCollection 2024 Jun.
4
Undiagnosed cardiovascular risk factors including elevated lipoprotein(a) in patients with ischaemic heart disease.
Front Epidemiol. 2023 Jul 17;3:1207752. doi: 10.3389/fepid.2023.1207752. eCollection 2023.
5
Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease.
J Am Coll Cardiol. 2024 Mar 5;83(9):873-886. doi: 10.1016/j.jacc.2023.12.031.
6
disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study.
Mol Ther Methods Clin Dev. 2022 Oct 13;27:337-351. doi: 10.1016/j.omtm.2022.10.009. eCollection 2022 Dec 8.
7
Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA).
Atherosclerosis. 2022 Dec;363:102-108. doi: 10.1016/j.atherosclerosis.2022.10.004. Epub 2022 Oct 8.
8
Elevated Lp(a) and course of COVID-19: Is there a relationship?
PLoS One. 2022 Jun 8;17(6):e0266814. doi: 10.1371/journal.pone.0266814. eCollection 2022.
9
Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care.
Front Genet. 2022 Apr 27;13:905941. doi: 10.3389/fgene.2022.905941. eCollection 2022.
10
Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: Design and rationale of the Mass General Brigham Lp(a) Registry.
Clin Cardiol. 2020 Nov;43(11):1209-1215. doi: 10.1002/clc.23456. Epub 2020 Sep 6.
本文引用的文献
1
Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups.
Circulation. 2019 Mar 19;139(12):1472-1482. doi: 10.1161/CIRCULATIONAHA.118.034311.
2
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.
Circulation. 2019 Mar 19;139(12):1483-1492. doi: 10.1161/CIRCULATIONAHA.118.037184.
3
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials.
Lancet. 2018 Oct 13;392(10155):1311-1320. doi: 10.1016/S0140-6736(18)31652-0. Epub 2018 Oct 4.
4
Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting.
Eur Heart J. 2018 Jul 14;39(27):2589-2596. doi: 10.1093/eurheartj/ehy334.
5
LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins.
Circulation. 2018 Oct 23;138(17):1839-1849. doi: 10.1161/CIRCULATIONAHA.117.031356.
6
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.
J Am Coll Cardiol. 2018 Jan 16;71(2):177-192. doi: 10.1016/j.jacc.2017.11.014.
7
Lipoprotein(a): new insights from modern genomics.
Curr Opin Lipidol. 2017 Apr;28(2):170-176. doi: 10.1097/MOL.0000000000000392.
8
Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study.
Atherosclerosis. 2017 Jan;256:47-52. doi: 10.1016/j.atherosclerosis.2016.11.010. Epub 2016 Nov 11.
9
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials.
Lancet. 2016 Nov 5;388(10057):2239-2253. doi: 10.1016/S0140-6736(16)31009-1. Epub 2016 Sep 21.
10
Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis.
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):996-1001. doi: 10.1161/ATVBAHA.114.304785. Epub 2015 Feb 19.
Zotero 插件